nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—melanoma—vitiligo	0.465	0.518	CtDrD
Docetaxel—skin cancer—vitiligo	0.432	0.482	CtDrD
Docetaxel—BCL2—The NLRP1 inflammasome—NLRP1—vitiligo	0.012	0.232	CbGpPWpGaD
Docetaxel—MAP4—hair follicle—vitiligo	0.00389	0.104	CbGeAlD
Docetaxel—BCL2—Inflammasomes—NLRP1—vitiligo	0.00263	0.0508	CbGpPWpGaD
Docetaxel—TUBB4B—skin epidermis—vitiligo	0.00259	0.0691	CbGeAlD
Docetaxel—MAPT—Caspase-mediated cleavage of cytoskeletal proteins—CASP7—vitiligo	0.00242	0.0467	CbGpPWpGaD
Docetaxel—BCL2—neck—vitiligo	0.00237	0.0634	CbGeAlD
Docetaxel—TUBB—hair follicle—vitiligo	0.00216	0.0579	CbGeAlD
Docetaxel—Lupus erythematosus—Methoxsalen—vitiligo	0.00208	0.155	CcSEcCtD
Docetaxel—MAP2—neck—vitiligo	0.00205	0.0549	CbGeAlD
Docetaxel—TUBB4B—hair follicle—vitiligo	0.00185	0.0493	CbGeAlD
Docetaxel—MAP4—skin of body—vitiligo	0.00169	0.0451	CbGeAlD
Docetaxel—MAPT—thyroid gland—vitiligo	0.00158	0.0422	CbGeAlD
Docetaxel—BCL2—skin of body—vitiligo	0.00153	0.041	CbGeAlD
Docetaxel—CYP1B1—hair follicle—vitiligo	0.00146	0.0391	CbGeAlD
Docetaxel—Systemic lupus erythematosus—Methoxsalen—vitiligo	0.0014	0.104	CcSEcCtD
Docetaxel—ABCC1—hair follicle—vitiligo	0.00131	0.0351	CbGeAlD
Docetaxel—Skin hyperpigmentation—Methoxsalen—vitiligo	0.0013	0.0969	CcSEcCtD
Docetaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NLRP1—vitiligo	0.00126	0.0244	CbGpPWpGaD
Docetaxel—MAP4—thyroid gland—vitiligo	0.00124	0.0332	CbGeAlD
Docetaxel—GHRHR—G alpha (s) signalling events—MC1R—vitiligo	0.00116	0.0224	CbGpPWpGaD
Docetaxel—Redness—Methoxsalen—vitiligo	0.00115	0.0854	CcSEcCtD
Docetaxel—BCL2—thyroid gland—vitiligo	0.00113	0.0302	CbGeAlD
Docetaxel—EGFR—thyroid gland—vitiligo	0.00112	0.0298	CbGeAlD
Docetaxel—EGFR—Stabilization and expansion of the E-cadherin adherens junction—LPP—vitiligo	0.00107	0.0208	CbGpPWpGaD
Docetaxel—TUBB4A—skin of body—vitiligo	0.00103	0.0275	CbGeAlD
Docetaxel—MAP2—thyroid gland—vitiligo	0.000978	0.0261	CbGeAlD
Docetaxel—MAPT—Apoptotic cleavage of cellular proteins—CASP7—vitiligo	0.000961	0.0186	CbGpPWpGaD
Docetaxel—TUBB2A—skin of body—vitiligo	0.000935	0.025	CbGeAlD
Docetaxel—TUBB6—skin of body—vitiligo	0.000922	0.0246	CbGeAlD
Docetaxel—BCL2—Direct p53 effectors—TYRP1—vitiligo	0.000915	0.0177	CbGpPWpGaD
Docetaxel—KIF11—Factors involved in megakaryocyte development and platelet production—SH2B3—vitiligo	0.000896	0.0173	CbGpPWpGaD
Docetaxel—MAPT—Kit receptor signaling pathway—MITF—vitiligo	0.000833	0.0161	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—LRR1—vitiligo	0.000821	0.0159	CbGpPWpGaD
Docetaxel—TUBB4B—skin of body—vitiligo	0.000801	0.0214	CbGeAlD
Docetaxel—Inflammation—Methoxsalen—vitiligo	0.000799	0.0594	CcSEcCtD
Docetaxel—TUBB4A—thyroid gland—vitiligo	0.000756	0.0202	CbGeAlD
Docetaxel—MAPT—Apoptotic execution phase—CASP7—vitiligo	0.000748	0.0144	CbGpPWpGaD
Docetaxel—BCL2—EPO signaling pathway—SH2B3—vitiligo	0.000745	0.0144	CbGpPWpGaD
Docetaxel—Skin exfoliation—Methoxsalen—vitiligo	0.00074	0.055	CcSEcCtD
Docetaxel—TUBB2B—thyroid gland—vitiligo	0.00073	0.0195	CbGeAlD
Docetaxel—TUBB—thyroid gland—vitiligo	0.000691	0.0185	CbGeAlD
Docetaxel—TUBB2A—thyroid gland—vitiligo	0.000688	0.0184	CbGeAlD
Docetaxel—TUBB6—thyroid gland—vitiligo	0.000678	0.0181	CbGeAlD
Docetaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP7—vitiligo	0.000661	0.0128	CbGpPWpGaD
Docetaxel—BCL2—Intrinsic Pathway for Apoptosis—GZMB—vitiligo	0.000645	0.0125	CbGpPWpGaD
Docetaxel—CYP1B1—skin of body—vitiligo	0.000635	0.017	CbGeAlD
Docetaxel—KIF11—Adaptive Immune System—HERC2—vitiligo	0.000622	0.012	CbGpPWpGaD
Docetaxel—ABCC10—thyroid gland—vitiligo	0.000594	0.0159	CbGeAlD
Docetaxel—BCL2—Intrinsic Pathway for Apoptosis—CASP7—vitiligo	0.000591	0.0114	CbGpPWpGaD
Docetaxel—TUBB4B—thyroid gland—vitiligo	0.000589	0.0158	CbGeAlD
Docetaxel—Dermatitis bullous—Methoxsalen—vitiligo	0.000588	0.0438	CcSEcCtD
Docetaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vitiligo	0.000576	0.0111	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—CASP7—vitiligo	0.000545	0.0105	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TYRP1—vitiligo	0.000541	0.0105	CbGpPWpGaD
Docetaxel—MAPT—IL-2 Signaling Pathway—IL2RA—vitiligo	0.00054	0.0104	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—CASP7—vitiligo	0.000535	0.0103	CbGpPWpGaD
Docetaxel—Dry skin—Methoxsalen—vitiligo	0.000515	0.0384	CcSEcCtD
Docetaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—SH2B3—vitiligo	0.000513	0.00991	CbGpPWpGaD
Docetaxel—BCL2—Kit receptor signaling pathway—MITF—vitiligo	0.000512	0.0099	CbGpPWpGaD
Docetaxel—KIF11—Immune System—LRR1—vitiligo	0.000498	0.00962	CbGpPWpGaD
Docetaxel—CYP1B1—thyroid gland—vitiligo	0.000467	0.0125	CbGeAlD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—GZMB—vitiligo	0.000466	0.00901	CbGpPWpGaD
Docetaxel—CYP1B1—Estrogen metabolism—GSTM1—vitiligo	0.000445	0.0086	CbGpPWpGaD
Docetaxel—BCL2—IL2 signaling events mediated by STAT5—IL2RA—vitiligo	0.000435	0.0084	CbGpPWpGaD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—CAT—vitiligo	0.000427	0.00826	CbGpPWpGaD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—CASP7—vitiligo	0.000427	0.00825	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—MC1R—vitiligo	0.000421	0.00813	CbGpPWpGaD
Docetaxel—ABCC1—thyroid gland—vitiligo	0.00042	0.0112	CbGeAlD
Docetaxel—KIF11—Immune System—NLRP1—vitiligo	0.000398	0.00769	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HERC2—vitiligo	0.000377	0.00729	CbGpPWpGaD
Docetaxel—BCL2—IL2 signaling events mediated by PI3K—IL2RA—vitiligo	0.000368	0.0071	CbGpPWpGaD
Docetaxel—ABCG2—thyroid gland—vitiligo	0.000348	0.00929	CbGeAlD
Docetaxel—Arrhythmia—Methoxsalen—vitiligo	0.000348	0.0259	CcSEcCtD
Docetaxel—BCL2—Apoptosis—GZMB—vitiligo	0.000342	0.00661	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—GZMB—vitiligo	0.000341	0.00658	CbGpPWpGaD
Docetaxel—Erythema—Methoxsalen—vitiligo	0.000339	0.0252	CcSEcCtD
Docetaxel—BCL2—IL-2 Signaling Pathway—IL2RA—vitiligo	0.000332	0.00642	CbGpPWpGaD
Docetaxel—Dysgeusia—Methoxsalen—vitiligo	0.000332	0.0247	CcSEcCtD
Docetaxel—Muscle spasms—Methoxsalen—vitiligo	0.000326	0.0242	CcSEcCtD
Docetaxel—GHRHR—GPCR ligand binding—CCR6—vitiligo	0.000314	0.00607	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—CASP7—vitiligo	0.000313	0.00605	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—SH2B3—vitiligo	0.000313	0.00605	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—CASP7—vitiligo	0.000312	0.00603	CbGpPWpGaD
Docetaxel—EGFR—a6b1 and a6b4 Integrin signaling—CASP7—vitiligo	0.000305	0.00589	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—CASP7—vitiligo	0.000294	0.00568	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—CASP7—vitiligo	0.000293	0.00565	CbGpPWpGaD
Docetaxel—CYP3A4—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.000287	0.00555	CbGpPWpGaD
Docetaxel—Oedema—Methoxsalen—vitiligo	0.000276	0.0206	CcSEcCtD
Docetaxel—Infection—Methoxsalen—vitiligo	0.000275	0.0204	CcSEcCtD
Docetaxel—BCL2—IL2-mediated signaling events—IL2RA—vitiligo	0.000272	0.00525	CbGpPWpGaD
Docetaxel—Skin disorder—Methoxsalen—vitiligo	0.000268	0.02	CcSEcCtD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.000264	0.0051	CbGpPWpGaD
Docetaxel—Hypotension—Methoxsalen—vitiligo	0.000258	0.0192	CcSEcCtD
Docetaxel—KIF11—Hemostasis—CD44—vitiligo	0.000254	0.00491	CbGpPWpGaD
Docetaxel—Insomnia—Methoxsalen—vitiligo	0.00025	0.0186	CcSEcCtD
Docetaxel—Dyspepsia—Methoxsalen—vitiligo	0.000243	0.0181	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Methoxsalen—vitiligo	0.000239	0.0178	CcSEcCtD
Docetaxel—GHRHR—GPCR downstream signaling—MC1R—vitiligo	0.000238	0.00459	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—CD44—vitiligo	0.000234	0.00451	CbGpPWpGaD
Docetaxel—Feeling abnormal—Methoxsalen—vitiligo	0.000228	0.0169	CcSEcCtD
Docetaxel—CYP1B1—Tryptophan metabolism—CAT—vitiligo	0.000223	0.0043	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—CASP7—vitiligo	0.000222	0.00429	CbGpPWpGaD
Docetaxel—Body temperature increased—Methoxsalen—vitiligo	0.000218	0.0163	CcSEcCtD
Docetaxel—KIF11—Adaptive Immune System—CTLA4—vitiligo	0.000216	0.00418	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—MC1R—vitiligo	0.000216	0.00417	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—GSTM1—vitiligo	0.000214	0.00413	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—GZMB—vitiligo	0.00021	0.00405	CbGpPWpGaD
Docetaxel—Hypersensitivity—Methoxsalen—vitiligo	0.000204	0.0152	CcSEcCtD
Docetaxel—Pruritus—Methoxsalen—vitiligo	0.000196	0.0146	CcSEcCtD
Docetaxel—BCL2—Apoptosis—CASP7—vitiligo	0.000192	0.00371	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—CAT—vitiligo	0.000184	0.00355	CbGpPWpGaD
Docetaxel—Dizziness—Methoxsalen—vitiligo	0.000183	0.0136	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—NLRP1—vitiligo	0.000179	0.00345	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—CCR6—vitiligo	0.000178	0.00343	CbGpPWpGaD
Docetaxel—Rash—Methoxsalen—vitiligo	0.000174	0.013	CcSEcCtD
Docetaxel—Dermatitis—Methoxsalen—vitiligo	0.000174	0.013	CcSEcCtD
Docetaxel—KIF11—Hemostasis—IL2RA—vitiligo	0.000174	0.00335	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CCR6—vitiligo	0.000173	0.00335	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IFIH1—vitiligo	0.000173	0.00335	CbGpPWpGaD
Docetaxel—Headache—Methoxsalen—vitiligo	0.000173	0.0129	CcSEcCtD
Docetaxel—ABCB1—thyroid gland—vitiligo	0.000171	0.00458	CbGeAlD
Docetaxel—KIF11—Adaptive Immune System—CD8A—vitiligo	0.000166	0.00322	CbGpPWpGaD
Docetaxel—Nausea—Methoxsalen—vitiligo	0.000164	0.0122	CcSEcCtD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.000162	0.00314	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—CCR6—vitiligo	0.000161	0.00312	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—IL2RA—vitiligo	0.000152	0.00293	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—DDX6—vitiligo	0.000143	0.00275	CbGpPWpGaD
Docetaxel—CYP3A4—Estrogen metabolism—GSTM1—vitiligo	0.000135	0.00261	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—SH2B3—vitiligo	0.000134	0.0026	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD44—vitiligo	0.000133	0.00257	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CTLA4—vitiligo	0.000131	0.00254	CbGpPWpGaD
Docetaxel—BCL2—Immune System—LRR1—vitiligo	0.00013	0.00251	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MC1R—vitiligo	0.000128	0.00246	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—LRR1—vitiligo	0.000127	0.00245	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD80—vitiligo	0.000125	0.00242	CbGpPWpGaD
Docetaxel—CYP1B1—Biological oxidations—GSTT1—vitiligo	0.000115	0.00222	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—GZMB—vitiligo	0.000107	0.00207	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—CASP7—vitiligo	0.000106	0.00205	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NLRP1—vitiligo	0.000106	0.00204	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NLRP1—vitiligo	0.000104	0.00201	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—GSTT1—vitiligo	0.000104	0.002	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD8A—vitiligo	0.000101	0.00195	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HERC2—vitiligo	9.86e-05	0.0019	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CASP7—vitiligo	9.82e-05	0.0019	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HERC2—vitiligo	9.61e-05	0.00186	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	9.6e-05	0.00185	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCR6—vitiligo	9.52e-05	0.00184	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—IL2RA—vitiligo	9.33e-05	0.0018	CbGpPWpGaD
Docetaxel—EGFR—Constitutive PI3K/AKT Signaling in Cancer—CD80—vitiligo	9.24e-05	0.00178	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL2RA—vitiligo	9.1e-05	0.00176	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—SH2B3—vitiligo	9.03e-05	0.00174	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—GZMB—vitiligo	8.97e-05	0.00173	CbGpPWpGaD
Docetaxel—ABCC2—NRF2 pathway—GSTM1—vitiligo	8.73e-05	0.00169	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CTLA4—vitiligo	8.62e-05	0.00167	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL2RA—vitiligo	8.47e-05	0.00164	CbGpPWpGaD
Docetaxel—EGFR—PI-3K cascade—CD80—vitiligo	8.32e-05	0.00161	CbGpPWpGaD
Docetaxel—EGFR—PI3K/AKT activation—CD80—vitiligo	8.12e-05	0.00157	CbGpPWpGaD
Docetaxel—EGFR—GAB1 signalosome—CD80—vitiligo	8.06e-05	0.00156	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—CD80—vitiligo	7.87e-05	0.00152	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CCR6—vitiligo	7.77e-05	0.0015	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IFIH1—vitiligo	7.77e-05	0.0015	CbGpPWpGaD
Docetaxel—EGFR—Immune System—LRR1—vitiligo	7.69e-05	0.00149	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD80—vitiligo	7.6e-05	0.00147	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—GSTT1—vitiligo	7.49e-05	0.00145	CbGpPWpGaD
Docetaxel—CYP1B1—Biological oxidations—GSTM1—vitiligo	7.32e-05	0.00141	CbGpPWpGaD
Docetaxel—CYP1B1—Metapathway biotransformation—GSTM1—vitiligo	7.22e-05	0.00139	CbGpPWpGaD
Docetaxel—CYP3A4—Tryptophan metabolism—CAT—vitiligo	6.74e-05	0.0013	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—GSTM1—vitiligo	6.6e-05	0.00127	CbGpPWpGaD
Docetaxel—CYP3A7—Metapathway biotransformation—GSTM1—vitiligo	6.51e-05	0.00126	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—CD80—vitiligo	6.22e-05	0.0012	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NLRP1—vitiligo	6.15e-05	0.00119	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL2RA—vitiligo	5.98e-05	0.00115	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—CD80—vitiligo	5.95e-05	0.00115	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—CD80—vitiligo	5.86e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HERC2—vitiligo	5.83e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—CD80—vitiligo	5.59e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—CD80—vitiligo	5.56e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—CD80—vitiligo	5.54e-05	0.00107	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—CD80—vitiligo	5.51e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—CD80—vitiligo	5.43e-05	0.00105	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—CD80—vitiligo	5.18e-05	0.001	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—CD80—vitiligo	5.18e-05	0.001	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—CD80—vitiligo	5.18e-05	0.001	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—CD80—vitiligo	5.14e-05	0.000993	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—CD80—vitiligo	5.09e-05	0.000984	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—CD80—vitiligo	5.07e-05	0.00098	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL2RA—vitiligo	5e-05	0.000967	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CD80—vitiligo	4.99e-05	0.000964	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	4.85e-05	0.000936	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—CD80—vitiligo	4.8e-05	0.000927	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—GSTM1—vitiligo	4.77e-05	0.000921	CbGpPWpGaD
Docetaxel—CYP3A5—Metapathway biotransformation—GSTM1—vitiligo	4.7e-05	0.000909	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IFIH1—vitiligo	4.59e-05	0.000888	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CCR6—vitiligo	4.59e-05	0.000888	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	4.59e-05	0.000887	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFIH1—vitiligo	4.53e-05	0.000874	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CCR6—vitiligo	4.53e-05	0.000874	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CD80—vitiligo	4.18e-05	0.000807	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MC1R—vitiligo	3.92e-05	0.000758	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—CD80—vitiligo	3.53e-05	0.000682	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—GSTT1—vitiligo	3.48e-05	0.000673	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD44—vitiligo	3.48e-05	0.000672	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTLA4—vitiligo	3.43e-05	0.000663	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD80—vitiligo	3.41e-05	0.000658	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CTLA4—vitiligo	3.34e-05	0.000646	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCR6—vitiligo	2.93e-05	0.000566	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GSTT1—vitiligo	2.87e-05	0.000555	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFIH1—vitiligo	2.68e-05	0.000517	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CCR6—vitiligo	2.68e-05	0.000517	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—vitiligo	2.64e-05	0.00051	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—vitiligo	2.57e-05	0.000497	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CD44—vitiligo	2.39e-05	0.000461	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2RA—vitiligo	2.38e-05	0.000459	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MC1R—vitiligo	2.32e-05	0.000448	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—GSTM1—vitiligo	2.22e-05	0.000428	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	2.19e-05	0.000423	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD44—vitiligo	2.06e-05	0.000398	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GSTT1—vitiligo	2.03e-05	0.000392	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTLA4—vitiligo	2.03e-05	0.000392	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD44—vitiligo	2.02e-05	0.000389	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD80—vitiligo	2.01e-05	0.000389	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD80—vitiligo	1.98e-05	0.000383	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GSTT1—vitiligo	1.96e-05	0.00038	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CAT—vitiligo	1.94e-05	0.000374	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD80—vitiligo	1.93e-05	0.000374	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD44—vitiligo	1.9e-05	0.000367	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GSTM1—vitiligo	1.83e-05	0.000354	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTT1—vitiligo	1.79e-05	0.000345	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTT1—vitiligo	1.77e-05	0.000342	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR6—vitiligo	1.73e-05	0.000334	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CD44—vitiligo	1.69e-05	0.000326	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SH2B3—vitiligo	1.64e-05	0.000317	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CD44—vitiligo	1.63e-05	0.000315	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GZMB—vitiligo	1.63e-05	0.000315	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—vitiligo	1.56e-05	0.000301	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2RA—vitiligo	1.54e-05	0.000297	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CD44—vitiligo	1.49e-05	0.000287	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CD44—vitiligo	1.47e-05	0.000284	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2RA—vitiligo	1.41e-05	0.000272	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CAT—vitiligo	1.37e-05	0.000265	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CAT—vitiligo	1.33e-05	0.000256	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GSTM1—vitiligo	1.29e-05	0.00025	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTT1—vitiligo	1.28e-05	0.000247	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GSTM1—vitiligo	1.25e-05	0.000242	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CAT—vitiligo	1.21e-05	0.000233	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CAT—vitiligo	1.19e-05	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD80—vitiligo	1.17e-05	0.000227	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD80—vitiligo	1.15e-05	0.000222	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTM1—vitiligo	1.14e-05	0.00022	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTM1—vitiligo	1.13e-05	0.000218	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD80—vitiligo	1.08e-05	0.000209	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CD44—vitiligo	1.06e-05	0.000206	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTT1—vitiligo	9.66e-06	0.000187	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2RA—vitiligo	9.09e-06	0.000176	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAT—vitiligo	8.64e-06	0.000167	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—vitiligo	8.16e-06	0.000158	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CD44—vitiligo	8.03e-06	0.000155	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CD80—vitiligo	7.59e-06	0.000147	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAT—vitiligo	6.52e-06	0.000126	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—vitiligo	6.16e-06	0.000119	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTT1—vitiligo	5.95e-06	0.000115	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CD44—vitiligo	4.95e-06	9.56e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAT—vitiligo	4.02e-06	7.76e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—vitiligo	3.79e-06	7.33e-05	CbGpPWpGaD
